Navigation Links
Advances in Cosmesis Increase Amputee Acceptance of Prosthesis and Orthotics Devices, Finds Frost & Sullivan
Date:12/12/2012

MOUNTAIN VIEW, Calif., Dec. 12, 2012 /PRNewswire/ -- The orthotics and prosthetics (O&P) industry is becoming a fertile ground for innovation because of the expanding patient pool of the elderly and disabled as well as numerous technological breakthroughs. The improving quality of O&P devices and services due to regular clinical interventions and integration of the interpreted data into patient care have considerably enhanced their uptake.

New analysis from Frost & Sullivan's (http://www.technicalinsights.frost.com) Advances in Bionic Prosthesis and Orthotics finds that the O&P industry is experiencing a blend of multiple streams of science and technology. Consequently, market participants must strategize to align competencies, capabilities and resources to expand their market share.

If you are interested in more information on this research, please email Britni Myers, Corporate Communications, at britni.myers@frost.com, with your full name, company name, job title, telephone number, company email address, company website, city, state and country.

"Advances in plastic fabrication, structures and materials help manufacturers produce better artificial limbs at a much quicker pace," said Technical Insights Research Analyst Saju John Mathew. "Further, the advent of microprocessors has transformed the overall prosthetics landscape."

Currently, many versions of prosthesis can be developed to fit a patient's varying motor skills, facilitating better functionality and integration with the patient's needs. Superior cosmesis enables the matching of the prosthetics with the patient's sound side to camouflage any disability.

However, there is always a risk of microbial infection during surgical insertion of a prosthetic in the body and this discourages its use. The Food and Drug Administration (FDA) can also peg back the newly conceived technology/product by delaying its commercial launch. In some instances, technology developers prefer to conduct their R&D overseas, citing regulatory delays.

O&P devices, specifically related to neurostimulation technologies, are still at an early stage of commercialization. Developers need to ensure smoother regulatory approvals to attract investors and partners, and to gain global market shares.

As the technology gets smarter and new materials and structures are invented, biocompatibility issues will be resolved. Miniaturization will further enhance the appeal of O&P devices among patients and boost the technology's adoption.

"A strong R&D network under one umbrella can help developers complement existing technologies and explore other applications," noted Mathew. "Additionally, a hassle-free R&D environment aids uninterrupted funding and technology transfer between partners to enhance the value of the developed technology/product."

Advances in Bionic Prosthesis and Orthotics, part of the Technical Insights subscription, outlines the R&D platform and the necessary factors required for the growth of the O&P industry. Further, this research service includes detailed technology analysis and industry trends evaluated following extensive interviews with market participants.

Technical Insights is an international technology analysis business that produces a variety of technical news alerts, newsletters and research services.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Advances in Bionic Prosthesis and Orthotics    
D2F7-TI

Contact:    
Britni Myers    
Corporate Communications – North America    
P: 210.477.8481    
F: 210.348.1003    
E: britni.myers@frost.com    

http://www.frost.com
http://www.technicalinsights.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
2. Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic
3. Medical Imaging Information Systems Market to 2017 - Replacement of Legacy Systems and Advances in Software Present Growth Opportunities
4. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
5. URAC sets standards for community pharmacy, advances dialogue about pharmacists as medication experts
6. Neurostimulation Devices Market to 2018 - Technological Advances and Robust Pipeline with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth
7. Pharmaceutical Supply Chain in the US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits
8. Accelrys ELN Advances Innovation Lifecycle Management with Enhanced Biology Capabilities from Screening to Preclinical Development
9. Advances in Delivery to the Central Nervous System
10. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
11. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE ... team that developed an innovative way to use nonlinear ... the delivery of new drugs. ... Clinical Dermatology Conference will show how researchers from BioPharmX ... Harvard Medical School used a suite of imaging techniques ...
(Date:10/11/2017)... 2017  True Health, a leader in integrated ... during National Breast Cancer Awareness month to educate ... Research recently published ... more than 10 million American women are at ... or BRCA2 and have not had testing. These mutations ...
(Date:10/10/2017)... 2017  NDS received FDA 510(k) clearance in May 2017 for ... stand specifically designed for endoscopy environments. An innovative secondary monitor solution, ... solution to support the improvement of patient outcomes, procedural efficiency, and ... ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... ... throughout Arkansas that offers insurance and financial preparation services, is providing an update ... City Rescue organization. , Rock City Rescue is a locally recognized nonprofit that ...
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family ... next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. ... 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the ...
(Date:10/13/2017)... EDWARDSVILLE, Ill. (PRWEB) , ... ... ... University Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and ... educated healthcare professionals on guideline updates for the primary prevention of cardiovascular ...
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids this ... by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited about ... ages; it is a non-competitive, non-timed event, which is all about having fun and ...
Breaking Medicine News(10 mins):